Managing conflicts of interest in clinical care: A national survey of policies at U.S. medical schools

Academic Medicine

Volumn 86, Issue 3, 2011, Pages 293-299

  Chimonas, Susan ^a   Patterson, Lisa ^a   Raveis, Victoria H ^b   Rothman, David J ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NEW YORK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79952186400     PISSN: 10402446     EISSN: None     Source Type: Journal    
DOI: 10.1097/ACM.0b013e3182087156     Document Type: Article

References (30)

1. Institute of Medicine. Conflict of Interest in Medical Research, Education, and Practice. Washington, DC: National Academies Press; 2009.
2. Association of American Medical Colleges Task Force on Financial Conflicts of Interest in Clinical Research. Protecting subjects, preserving trust, promoting progress II: Principles and recommendations for oversight of an institution's financial interests in human subjects research. Acad Med. 2003; 78:237-245. http://journals.lww.com/academicmedicine/Fulltext/2003/02000/ Protecting-Subjects,-Preserving-Trust,-Promoting.24.aspx. Accessed November 18, 2010.
3. Korn D, Ehringhaus S. Principles for strengthening the integrity of clinical research. PLoS Clin Trials. May 2006;1:e1.
4. DeAngelis CD, Fontanarosa PB, Flanagin A. Reporting financial conflicts of interest and relationships between investigators and research sponsors. JAMA. 2001;286: 89-91. (Pubitemid 32606337)
5. Association of American Medical Colleges Task Force on Conflicts of Interest in Clinical Research. Protecting subjects, preserving trust, promoting progress I: Policy and guidelines for the oversight of individual financial interests in human subjects research. Acad Med. 2003;78:225-236. http://journals.lww.com/academicmedicine/Fulltext/2003/02000/ Protecting-Subjects,-Preserving-Trust,-Promoting.23.aspx. Accessed November 18, 2010.
6. Lichter PR. Biomedical research, conflict of interest, and the public trust. Ophthalmology. 1989;96:575-578.
7. Bero LA. Managing financial conflicts of interest in research. J Am Coll Dent. Summer 2005;72:4-9.
8. Kassirer JP, Angell M. Financial conflicts of interest in biomedical research. N Engl J Med. 1993;329:570-571. (Pubitemid 23232628)
9. Blumenthal D. Conflict of interest in biomedical research. Health Matrix Clevel. 2002;12:377-392.
10. Wazana A. Gifts to physicians from the pharmaceutical industry. JAMA. 2000;283:2655-2658.
11. Chimonas S, Rothman DJ. New federal guidelines for physician- pharmaceutical industry relations: The politics of policy formation. Health Aff (Millwood). 2005;24:949-960. (Pubitemid 41058594)
12. Blumenthal D. Doctors and drug companies. N Engl J Med. 2004;351:1885-1890. (Pubitemid 39426325)
13. Kassirer JP. Physicians on the take. MedGenMed. 2006;8:74.
14. Campbell EG. Doctors and drug companies-Scrutinizing influential relationships. N Engl J Med. 2007;357:1796-1797. (Pubitemid 350044799)
15. Dana J, Loewenstein G. A social science perspective on gifts to physicians from industry. JAMA. 2003;290: 252-255. (Pubitemid 37430065)
16. Association of American Medical Colleges and Baylor College of Medicine Department of Neuroscience and Computational Psychiatry Unit. Conference proceedings from The Scientific Basis of Influence and Reciprocity: A Symposium. Washington, DC: AAMC; 2007.
17. Cutrona SL, Woolhandler S, Lasser KE, Bor DH, McCormick D, Himmelstein DU. Characteristics of recipients of free prescription drug samples: A nationally representative analysis. Am J Public Health. 2008;98:284-289. (Pubitemid 351317563)
18. Adair RF, Holmgren LR. Do drug samples influence resident prescribing behavior? A randomized trial. Am J Med. 2005;118: 881-884. (Pubitemid 41097466)
19. Brennan TA, Rothman DJ, Blank L, et al. Health industry practices that create conflicts of interest: A policy proposal for academic medical centers. JAMA. 2006;295: 429-433. (Pubitemid 43144979)
20. Rothman DJ, Chimonas S. New developments in managing physician-industry relationships. JAMA. 2008;300:1067-1069.
21. Association of American Medical Colleges. Industry Funding of Medical Education: Report of an AAMC Task Force. Washington, DC: AAMC; June 2008.
22. New York Times Editorial Board. Seducing the medical profession. New York Times. February 2, 2006:A22.
23. American Medical Student Association. AMSA PharmFree Scorecard 2009. http://www.amsascorecard.org/methodology. Accessed November 9, 2010.
24. Institute on Medicine as a Profession. Conflicts of interest best practices. http://www.imapny.org/conflicts-of-interest/best-practices-tool-kits. Accessed November 17, 2010.
25. Chimonas S, Patterson L, Rothman D. Toeing the line. With added scrutiny, vendors heeding physician marketing rules. Mod Healthc. 2008;38:20.
26. Ehringhaus SH, Weissman JS, Sears JL, Goold SD, Feibelmann S, Campbell EG. Responses of medical schools to institutional conflicts of interest. JAMA. 2008;299:665-671. (Pubitemid 351252724)
27. Wilson D, Singer N. Ghostwriting is called rife in medical journals. New York Times. September 11, 2009:B5.
28. Singer N. Medical papers by ghostwriters pushed therapy. New York Times. August 4, 2009:A1.
29. Ross JS, Hill KP, Egilman DS, et al. Guest authorship and ghostwriting in publications related to rofecoxib: A case study of industry documents from rofecoxib litigation. JAMA. 2008;299:1800-1812. (Pubitemid 351549971)
30. Department of Health and Human Services. 42 CFR Part 50, 45 CFR Part 94: Responsibility of applicants for promoting objectivity in research for which PHS funding is sought and responsible prospective contractors; proposed rule. Volume 75, Federal Register, 2010:28688-28712.